Borsini F, Nowakowska E, Pulvirenti L, Samanin R
J Pharm Pharmacol. 1985 Feb;37(2):137-8. doi: 10.1111/j.2042-7158.1985.tb05025.x.
Seven days of treatment with amitriptyline 10 mg kg-1 day-1, reduced the immobility time in the behavioural 'despair' test in rats. 0.5, but not 0.25 mg kg-1 haloperidol significantly counteracted the reduction of immobility caused by amitriptyline. Its anti-immobility effect was reduced by 50 and 100 mg kg-1 sulpiride, another blocker of dopamine receptors, and 5 mg kg-1 (+/-)-propranolol, a beta-adrenolytic drug. Prazosin, 3 mg kg-1, an antagonist of post-synaptic alpha-adrenoceptors, had no effect. It is suggested that dopaminergic and beta-adrenoceptors mediate the anti-immobility effect of repeated amitriptyline treatment in rats.
每天以10毫克/千克的剂量给大鼠服用阿米替林进行为期七天的治疗,可减少大鼠行为“绝望”试验中的不动时间。0.5毫克/千克的氟哌啶醇(而非0.25毫克/千克)可显著抵消阿米替林引起的不动时间减少。多巴胺受体的另一种阻滞剂50毫克/千克和100毫克/千克的舒必利以及β-肾上腺素能阻断药5毫克/千克的(±)-普萘洛尔可降低其抗不动作用。3毫克/千克的突触后α-肾上腺素能受体拮抗剂哌唑嗪则无作用。研究表明,多巴胺能和β-肾上腺素能受体介导了大鼠重复服用阿米替林治疗的抗不动作用。